UTI (NYSE: UTI) files notice to resell 748 and 3,797 vesting shares

Rhea-AI Filing Summary

UTI submitted a Form 144 notice listing proposed sales tied to restricted stock vesting. The filing lists 748 shares tied to a 12/08/2023 vesting event and 3,797 shares tied to a 12/08/2024 vesting event. The excerpt also shows an entry with numeric fields including 181800.00 and the date 06/22/2026.

Insights

Securities Counsel

Filing lists proposed resale of vested restricted shares with specific vesting dates and share counts.

The notice records two restricted stock vesting events: 748 shares vested on 12/08/2023 and 3,797 shares vested on 12/08/2024

Timing, methods of sale, and purchaser details are not shown in the excerpt; subsequent filings or broker confirmations would clarify execution details and proceeds treatment.

Key Figures

Vesting shares (Dec 8, 2023): 748 shares Vesting shares (Dec 8, 2024): 3,797 shares Numeric entry shown: 181800.00 +1 more

4 metrics

Vesting shares (Dec 8, 2023) 748 shares Restricted Stock Vesting on 12/08/2023

Vesting shares (Dec 8, 2024) 3,797 shares Restricted Stock Vesting on 12/08/2024

Numeric entry shown 181800.00 Listed with other security fields and date 06/22/2026

Identifier/number 55061381 Appears in the securities line with exchange NYSE

Key Terms

Restricted Stock Vesting, Securities To Be Sold, Issuer

3 terms

Restricted Stock Vesting regulatory

"Common | 12/08/2023 | Restricted Stock Vesting | Issuer"

Restricted stock vesting is the timetable and conditions under which shares granted to employees or insiders become fully owned and can be sold, typically requiring continued work or meeting performance goals. It matters to investors because large blocks of shares can become tradable at once, which can change share supply and price, and because vesting aligns insiders’ incentives with the company’s long‑term performance—think of it like a timed unlock that both rewards and locks in key people.

Securities To Be Sold regulatory

"144: Securities To Be Sold"

Issuer financial

"Restricted Stock Vesting | Issuer"

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 06/22/2026 - 10:42 AM Accepted by SEC EDGAR 06/22/2026 - 10:42 AM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Fidelity Brokerage Services LLC 900 Salem Street Smithfield RI 02917	4545	181800.00	55061381	06/22/2026	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	12/08/2023	Restricted Stock Vesting	Issuer			748	12/08/2023	Compensation
Common	12/08/2024	Restricted Stock Vesting	Issuer			3797	12/08/2024	Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does UTI's Form 144 show about restricted stock vesting?

The filing lists 748 shares vesting on 12/08/2023 and 3,797 shares vesting on 12/08/2024. It records proposed sales tied to those vesting events without specifying sale mechanics or proceeds recipients.

Does the Form 144 excerpt state who will receive the sale proceeds for UTI?

The excerpt does not specify the recipient of proceeds. It lists vesting events and share counts but does not state whether proceeds go to the issuer or selling holder or provide sale pricing or proceeds allocation.

Are the dates and share counts in UTI's filing definitive for sale timing?

The filing records vesting dates 12/08/2023 and 12/08/2024 for specified share counts; it does not state actual sale dates or confirm execution. Sale timing may follow in subsequent transaction reports or broker records.

What other numeric entries appear in the UTI excerpt and what do they indicate?

The excerpt includes a numeric sequence showing 181800.00 and the date 06/22/2026, plus an identifier 55061381. The excerpt does not provide labels that explain these values within the provided text.